Mary Rose Gaylor, MD

Dr. Abimbola Aina-Mumuney is an assistant professor in the Johns Hopkins Medicine Department of Gynecology and Obstetrics. Her areas of clinical expertise include high-risk pregnancy conditions and prevention of preterm labor. Dr. Aina-Mumuney received her undergraduate and master’s degrees in chemistry from Harvard and Radcliffe colleges. She earned her M.D. from Harvard Medical School and completed her residency in obstetrics and gynecology at Henry Ford Hospital. Dr. Aina-Mumuney came to Johns Hopkins to perform a fellowship in maternal-fetal medicine before joining the faculty in 2004. Dr. Aina-Mumuney’s research interests include thrombophilia in pregnancy, preterm labor and cervical incompetence. In 2009, she teamed up with Johns Hopkins biomedical engineering graduate students to develop a new uterine monitoring system. The students have established a start-up company, CervoCheck for which Dr. Aina-Mumuney now serves as clinical consultant. With her assistance, they have been awarded numerous grants and awards from the Maryland Technology Development Corporation, the Technology Accelerator Fund and the LifeBridge Health Entrepreneur Challenge. Most recently, she was awarded a grant from the National Institutes of Child Health and Human Development as principal investigator. Their device has been patented and is currently being tested in an ovine model.Dr. Aina is a fellow of the American College of Obstetricians and Gynecologists and a member of The Society for Maternal-Fetal Medicine. She has served as a reviewer for several medical journals, including the American Journal of Obstetrics and Gynecology, Clinical and Experimental Hypertension and Gynecologic and Obstetric Investigation. Dr. Aina has published numerous peer-reviewed research articles on preterm labor and perinatal disease. Dr. Aina-Mumuney also has an interest in education and often participates in the mentoring of residents and fellows.

Dr. Katherine Hoops is an attending physician in the Pediatric Intensive Care Unit. Dr. Hoops’ research is focused on the prevention of firearm injury and violence. She is a core faculty member in the Johns Hopkins Bloomberg School of Public Health’s Center for Gun Violence Solutions, where she leads the Clinical Programs and Practice Team. She conducts research investigating how clinicians and health systems can prevent youth violence and injury while promoting healing and resilience through community-engaged, trauma-sensitive care. She received her undergraduate degree from Florida State University in Tallahassee, Florida. She earned her medical degree at the University of Miami Miller School of Medicine in Miami, Florida. She completed a Master’s in Public Health concentrating on Health Policy and Management in injury and violence prevention at the Johns Hopkins Bloomberg School of Public Health. She completed her residency training in Pediatrics at the University of Alabama Birmingham before coming to Johns Hopkins University School of Medicine to complete her fellowship in Pediatric Critical Care Medicine. In 2024, she completed her Juris Doctor Degree at the Georgetown University Law Center..

Dr. Calixto-Hope G. Lucas Jr. is an Assistant Professor of Pathology at the Johns Hopkins University School of Medicine. He serves as Director of the Clinical Neuropathology Service, Associate Program Director of the Anatomic Pathology Residency Program, and Course Director of Organ Systems Foundations of Medicine: Neoplasia. Dr. Lucas earned his B.S. degree in Molecular and Cellular Biology & History of Science, Medicine, and Technology from Johns Hopkins University in 2014 and M.D. degree from University of California, San Francisco in 2018. He continued on at University of California, San Francisco and completed residency training in anatomic pathology and fellowship training in neuropathology while serving as pathology chief resident. He now returns to Johns Hopkins and joins the Division of Neuropathology. His main academic interest is in brain tumor pathology, with emphasis on molecular neuropathology, pediatric gliomas, and neoplasms arising in patients with tumor predisposition syndromes. He frequently works in collaboration with clinical colleagues and has prior experience with next-generation sequencing, DNA methylation profiling, and spatial proteomic and transcriptomic techniques. He hopes to continue to leverage multiplatform sequencing approaches to refine existing codification schemes and develop assays that can be translated to clinical neuropathology and neurooncology practice.